Ristova 500 mg Injection ( Rituximab)
Manufacturer: Roche Products India Pvt Ltd
Medicine composition: Rituximab
Ristova 500Mg Injection acts as a monoclonal antibody. This drug is relatively new and is used to offer targeted therapy to treat cancer. Ristova 500Mg Injection only targets cancer cells in the body, thus the drug is less harmful as compared to Ristova 500Mg Injection radiation treatment.
Ristova 500Mg Injection is used to treat chronic lymphocytic leukemia and some types of non-hodgkin’s lymphoma.